CYTRX ltCYTR UNIT BUYS SWEDISH COMPANY
  CytRx Corp said its 60 pct owned CytRx
  Biopool Ltd subsidiary has acquired Biopool AB of Umea Sweden
  for undisclosed terms
      It said former shareholders of Biopool AB own the remaining
  40 pct in CytRx Biopool Ltd Biopool AB develops cardiovascular
  and fibrinolytic products for diagnostic applications
      The company said CytRx Biopool is studying the possible
  combination of CytRx Corps RheothRx drug to reduce platelet
  aggregation and viscosity in blood with Biopool ABs drug tPA
  for dissolving blood clots
  

